You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française


Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)      Intent: Curative
Regimen Category: evidence-informed
ODB - General Benefit
Exceptional Access Program
    iMAtinib - Adults with newly diagnosed Ph+ ALL, with specific criteria

You might also be interested in